Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.

Foj L, Filella X.

Pathol Oncol Res. 2018 Oct 26. doi: 10.1007/s12253-018-0508-3. [Epub ahead of print]

PMID:
30367364
2.

Novel Biomarkers for Prostate Cancer Detection and Prognosis.

Filella X, Foj L.

Adv Exp Med Biol. 2018;1095:15-39. doi: 10.1007/978-3-319-95693-0_2.

PMID:
30229547
3.

Emerging biomarkers in the diagnosis of prostate cancer.

Filella X, Fernández-Galan E, Fernández Bonifacio R, Foj L.

Pharmgenomics Pers Med. 2018 May 16;11:83-94. doi: 10.2147/PGPM.S136026. eCollection 2018. Review.

4.

Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.

Florez H, Mandelikova S, Filella X, Monegal A, Guañabens N, Peris P.

Med Clin (Barc). 2018 Jul 23;151(2):65-67. doi: 10.1016/j.medcli.2017.11.036. Epub 2017 Dec 30. English, Spanish.

PMID:
29295788
5.

Concordance between direct and indirect measurements of free 25-OH vitamin D.

Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat study group.

Clin Chim Acta. 2017 Dec;475:169-171. doi: 10.1016/j.cca.2017.10.016. Epub 2017 Oct 19.

PMID:
29056531
6.

Analytical verification and method comparison of the ADVIA Centaur® Intact Parathyroid Hormone assay.

Fernández-Galán E, Bedini JL, Filella X.

Clin Biochem. 2017 Dec;50(18):1222-1227. doi: 10.1016/j.clinbiochem.2017.09.006. Epub 2017 Sep 11.

PMID:
28912096
7.

High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.

Dlouhy I, Filella X, Rovira J, Magnano L, Rivas-Delgado A, Baumann T, Martínez-Trillos A, Balagué O, Martínez A, González-Farre B, Karube K, Gine E, Delgado J, Campo E, López-Guillermo A.

Leuk Res. 2017 Aug;59:20-25. doi: 10.1016/j.leukres.2017.05.014. Epub 2017 May 17.

PMID:
28544905
8.

Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.

Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.

Prostate. 2017 May;77(6):573-583. doi: 10.1002/pros.23295. Epub 2016 Dec 19.

PMID:
27990656
9.
10.

Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.

Parra-Robert M, Orois A, Augé JM, Halperin I, Filella X, Molina R.

Clin Chem Lab Med. 2017 Mar 1;55(3):441-446. doi: 10.1515/cclm-2016-0572.

PMID:
27754959
11.

Automated measurement of 25-OH Vitamin D on the LUMIPULSE® G1200: analytical verification and method comparison.

Parra M, Foj L, Filella X.

Br J Biomed Sci. 2016 Jul;73(3):104-109. Epub 2016 Jun 16.

PMID:
27310165
12.

Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.

Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J.

Clin Lymphoma Myeloma Leuk. 2016 Jun;16(6):e71-7. doi: 10.1016/j.clml.2016.02.034. Epub 2016 Feb 27.

PMID:
27013181
13.

miRNAs as novel biomarkers in the management of prostate cancer.

Filella X, Foj L.

Clin Chem Lab Med. 2017 May 1;55(5):715-736. doi: 10.1515/cclm-2015-1073. Review.

14.

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.

Molina R, Marrades RM, Augé JM, Escudero JM, Viñolas N, Reguart N, Ramirez J, Filella X, Molins L, Agustí A.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):427-37. doi: 10.1164/rccm.201404-0603OC.

PMID:
26465739
15.

Identification of Candidates for Active Surveillance: Should We Change the Current Paradigm?

Alcover J, Filella X.

Clin Genitourin Cancer. 2015 Dec;13(6):499-504. doi: 10.1016/j.clgc.2015.06.001. Epub 2015 Jun 16. Review.

PMID:
26194410
16.

Reference intervals for bone turnover markers in Spanish premenopausal women.

Guañabens N, Filella X, Monegal A, Gómez-Vaquero C, Bonet M, Buquet D, Casado E, Cerdá D, Erra A, Martinez S, Montalá N, Pitarch C, Kanterewicz E, Sala M, Surís X, Torres F; LabOscat Study Group.

Clin Chem Lab Med. 2016 Feb;54(2):293-303. doi: 10.1515/cclm-2015-0162.

17.

Emerging biomarkers in the detection and prognosis of prostate cancer.

Filella X, Foj L.

Clin Chem Lab Med. 2015 Jun;53(7):963-73. doi: 10.1515/cclm-2014-0988. Review.

18.

Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.

Gifre L, Vidal J, Carrasco JL, Filella X, Ruiz-Gaspà S, Muxi A, Portell E, Monegal A, Guañabens N, Peris P.

J Bone Miner Res. 2015 Jun;30(6):1014-21. doi: 10.1002/jbmr.2423.

19.

Prospective study of individualized or high fixed doses of vitamin D supplementation after bariatric surgery.

Flores L, Moizé V, Ortega E, Rodríguez L, Andreu A, Filella X, Vidal J.

Obes Surg. 2015 Mar;25(3):470-6. doi: 10.1007/s11695-014-1393-9.

PMID:
25086955
20.

The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 μg/L.

Filella X, Foj L, Alcover J, Augé JM, Molina R, Jiménez W.

Clin Chim Acta. 2014 Sep 25;436:303-7. doi: 10.1016/j.cca.2014.06.019. Epub 2014 Jun 27.

PMID:
24978824

Supplemental Content

Loading ...
Support Center